Voyager Therapeutics, Inc. share price logo

Voyager Therapeutics, Inc. Share Price

NASDAQ: VYGR

Small Cap

$4.58

-0.09

(-1.93%)

Live

as on

Voyager Therapeutics, Inc. Stock Performance

as on November 3, 2025 at 10:42 pm IST

  • Day's Low

    Day's High

    $4.45
    $4.67
    downward going graph

    2.84%

    Downside

    1.97%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.65
    $7.44
    downward going graph

    42.25%

    Downside

    62.52%

    Upside

    downward going graph

Voyager Therapeutics, Inc. share price movements today

Previous Close
$4.67
Open
$4.67
Volume
314.6K
Day's Low - High
$4.45 - $4.67
52 Week Low - High
$2.65 - $7.44

Voyager Therapeutics, Inc. Historical Returns

1 Month Return
-3.91 %
3 Month Return
+ 57.77 %
1 Year Return
-33.29 %
3 Year Return
-9.85 %
5 Year Return
-56.68 %

Voyager Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Voyager Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$259.0M

EPS (TTM)

-2.1052

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

39.47

Industry PE ratio

-0.8126129032258065

PEG Ratio

0

EBITDA

-118.9M

Revenue (TTM)

42.6M

Profit Margin

-253.49%

Return On Equity TTM

-37.26%

Voyager Therapeutics, Inc. Stock Valuation

Track how Voyager Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Voyager Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-168.84x)

March 31, 2024

Industry (-0.81x)

November 3, 2025

Today (39.47x)

November 3, 2025

Highest (29.94x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 39.47x

Voyager Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Voyager Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Voyager Therapeutics, Inc. image
Voyager Therapeutics, Inc.
BUY$259.0M-56.68%39.47-253.49%
Insmed Incorporated image
Insmed Incorporated
BUY$40.4B478.23%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.2B253.38%1425.121.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$109.1B101.56%30.3131.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$68.5B16.98%15.6232.13%

Stock Returns calculator for Voyager Therapeutics, Inc. Stock including INR - Dollar returns

The Voyager Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Voyager Therapeutics, Inc. investment value today

Current value as on today

₹71,130

Returns

₹28,870

(-28.87%)

Returns from Voyager Therapeutics, Inc. Stock

₹34,571 (-34.57%)

Dollar Returns*

₹5,701 (+5.7%)

Analyst Recommendation on Voyager Therapeutics, Inc. Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Voyager Therapeutics, Inc.. Average target price of $15.67

Voyager Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Voyager Therapeutics, Inc..

What analysts predicted

70.77%UPSIDE

Target Price

$15.67

Current Price

$4.58

Analyzed by

16 Analysts

Target

$15.67

Voyager Therapeutics, Inc. target price $15.67, a slight upside of 70.77% compared to current price of $4.58. According to 16 analysts rating.

Voyager Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Voyager Therapeutics, Inc. Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Voyager Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
150
4
4
90
19
29
24
6
6
5
Gross Profit
131
3
3
88
18
-4
24
6
6
5
Operating Income
122
-25
-29
54
-16
-15
-13
-38
-34
-36
EBITDA
123
-24
-28
55
-14
-13
-12
-37
-33
-35
Interest Expense
2
3
-
-
-
-
-
-
-
-
Depreciation
1
1
0
1
1
1
1
1
1
1
Income Before Tax
124
-22
-26
57
-11
-10
-9
-33
-30
-33
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
124
-22
-25
56
-11
-10
-9
-34
-31
-33
Net Profit Margin
82.43%
-457.61%
-561.36%
62.62%
-58.05%
-34.29%
-36.72%
-549.33%
-479.24%
-641.96%

Voyager Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
17
14
10
7
104
171
37
40
250
80
Gross Profit
17
14
10
7
104
62
37
40
245
80
Operating Income
-20
-41
-71
-91
-51
27
-73
-50
122
-83
EBITDA
-19
-40
-70
-88
-48
31
-68
-44
126
-78
Interest Expense
0
0
-
-
-
-
0
1
-
-
Depreciation
-
-
1
2
2
3
5
6
4
4
Income Before Tax
-29
-40
-70
-88
-43
36
-71
-46
133
-64
Income Tax Expense
0
0
-1
0
-2
-1
-5
0
1
0
Net Income
-29
-40
-70
-88
-40
36
-66
-46
132
-65
Net Profit Margin
-171.18%
-282.65%
-697.56%
-1158.79%
-39.11%
21.47%
-176.49%
-113.45%
52.93%
-81.25%

Voyager Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-22
-25
56
-11
-10
-9
-34
-31
-33
Operating Cash Flow
0
-21
-23
58
-31
-27
-14
-37
-33
Investing Cash Flow
-24
-158
26
-96
-35
64
-27
41
1
Financing Cash Flow
1
0
0
112
0
0
0
0
0
Change in Cash
-23
-179
3
75
-66
36
-41
3
-30

Voyager Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-40
-70
-88
-43
36
-71
-46
132
-65
Operating Cash Flow
-42
-61
-15
48
-96
-53
-12
77
-15
Investing Cash Flow
47
-3
26
-90
112
65
-7
-141
-94
Financing Cash Flow
0
59
4
80
3
0
1
33
114
Change in Cash
5
-5
15
39
19
12
-18
-30
3

Global Institutional Holdings in Voyager Therapeutics, Inc.

Funds
Holdings
BlackRock Inc
10.33%
Armistice Capital, LLC
8.65%
EcoR1 Capital, LLC
7.06%
Vanguard Group Inc
5.79%
Vestal Point Capital LP
2.66%
See all

Insights on Voyager Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, VYGR stock has moved up by 57.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 177.5% return, outperforming this stock by 210.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 958.0% return, outperforming this stock by 967.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -31.02M → -33.38M (in $), with an average decrease of 7.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.47M → 5.2M (in $), with an average decrease of 19.7% per quarter

About Voyager Therapeutics, Inc.

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.
OrganisationVoyager Therapeutics, Inc.
Headquarters75 Hayden Avenue, Lexington, MA, United States, 02421
IndustryHealth Technology
CEODr. Alfred W. Sandrock Jr., M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Voyager Therapeutics, Inc.

Name

Title

Dr. Alfred W. Sandrock Jr., M.D., Ph.D.

President, CEO & Director

Dr. Nathan D. Jorgensen M.B.A., Ph.D.

CFO, Principal Financial Officer & Principal Accounting Officer

Mr. Toby Ferguson M.D., Ph.D.

Chief Medical Officer

Dr. Krystof Bankiewicz M.D., Ph.D.

Founder

Dr. Mark A. Kay M.D., Ph.D.

Founder

Ms. Robin Swartz

Chief Business Officer & COO

Mr. Todd Carter Ph.D.

Chief Scientific Officer

Ms. Trista Morrison

Chief Corporate Affairs Officer & Chief of Staff to the CEO

FAQs

What is Voyager Therapeutics, Inc. share price today?

Voyager Therapeutics, Inc. share price today is $4.58 as on . Voyager Therapeutics, Inc. share today touched a day high of $4.67 and a low of $4.45.

What is the 52 week high and 52 week low for Voyager Therapeutics, Inc. share?

Voyager Therapeutics, Inc. share touched a 52 week high of $7.44 on and a 52 week low of $2.65 on . Voyager Therapeutics, Inc. stock price today i.e. is trending at $4.58,which is 38.47% down from its 52 week high and 73.16% up from its 52 week low.

What is Voyager Therapeutics, Inc.'s market capitalisation today?

Voyager Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Voyager Therapeutics, Inc. Stock (VYGR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Voyager Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Voyager Therapeutics, Inc. Shares that will get you 0.3275 shares as per Voyager Therapeutics, Inc. share price of $4.58 per share as on November 3, 2025 at 10:42 pm IST.

What is the minimum amount required to buy Voyager Therapeutics, Inc. Stock (VYGR) from India?

Indian investors can start investing in Voyager Therapeutics, Inc. (VYGR) shares with as little as ₹88.715 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.15 in Voyager Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Voyager Therapeutics, Inc. share’s latest price of $4.58 as on November 3, 2025 at 10:42 pm IST, you will get 2.1834 shares of Voyager Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Voyager Therapeutics, Inc. has given to Indian investors in the last 5 years?

Voyager Therapeutics, Inc. stock has given -56.68% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?